Karine Faure - Publications

Affiliations: 
Lille 2 

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dessein R, Bauduin M, Grandjean T, Le Guern R, Figeac M, Beury D, Faure K, Faveeuw C, Guery B, Gosset P, Kipnis E. Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice. Critical Care (London, England). 24: 611. PMID 33076936 DOI: 10.1186/s13054-020-03320-8  0.647
2019 Beury D, Fléchon L, Maurier F, Caboche S, Varré JS, Touzet H, Faure K, Dubuisson J, Hot D, Guery B, Goffard A. Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 122: 104206. PMID 31783264 DOI: 10.1016/J.Jcv.2019.104206  0.581
2019 Bortolotti P, Kipnis E, Faure E, Faure K, Wacrenier A, Fauquembergue M, Penven M, Messaadi S, Marceau L, Dessein R, Le Guern R. Clostridium ventriculi bacteremia following acute colonic pseudo-obstruction: A case report. Anaerobe. 59: 32-34. PMID 31103530 DOI: 10.1016/J.Anaerobe.2019.05.005  0.314
2019 Guern RL, Grandjean T, Bauduin M, Figeac M, Millot G, Loquet A, Faure K, Kipnis E, Dessein R. The Impact of Timing of Antibiotics on Digestive Colonization with Carbapenemase-Producing in a Murine Model. Antimicrobial Agents and Chemotherapy. PMID 30962336 DOI: 10.1128/Aac.00360-19  0.34
2017 Prevotat A, Rouyer C, Gosset P, Kipnis E, Faure K, Guery B. Biphasic lung injury during Streptococcus pneumoniae infection in a murine model. Medecine Et Maladies Infectieuses. PMID 29191391 DOI: 10.1016/J.Medmal.2017.11.001  0.489
2017 Lopez B, Boucher A, Bahuaud M, Mortuaire G, Melliez H, Launay D, Terriou L, Wemeau-Stervinou L, Wallaert B, Faure K, Wallet F, Hachulla E, Hatron PY, Dubucquoi S, Batteux F, et al. Specific polysaccharide antibody deficiency revealed by severe bacterial infections in adulthood: a report on eleven cases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28379361 DOI: 10.1093/Cid/Cix284  0.355
2017 Sanges S, Wallet F, Blondiaux N, Theis D, Verin I, Vachée A, Dessein R, Faure K, Viget N, Senneville E, Leroy O, Maury F, Just N, Poissy J, Mathieu D, et al. Diagnosis of primary antibody and complement immunodeficiencies in young adults after a first invasive bacterial infection. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28192236 DOI: 10.1016/J.Cmi.2017.02.005  0.329
2016 Mambie A, Wallet F, Scherman L, Armand S, Vervelle C, Faure K, Guery B, Titécat M, Loïez C. Neither Neoplasia Nor Tuberculosis, but Francisella. Open Forum Infectious Diseases. 3: ofw080. PMID 27419157 DOI: 10.1093/Ofid/Ofw080  0.571
2016 Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, Le Gouellec A. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship. Bmc Microbiology. 16: 137. PMID 27392067 DOI: 10.1186/S12866-016-0756-X  0.784
2016 Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Medecine Et Maladies Infectieuses. PMID 27210283 DOI: 10.1016/J.Medmal.2016.04.008  0.568
2016 Faure E, Bortolotti P, Kipnis E, Faure K, Guery B. Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways. Journal of Visualized Experiments : Jove. PMID 26863066 DOI: 10.3791/53218  0.641
2016 Deconinck L, Flateau C, Pichenot M, Morell-Dubois S, Maillard H, Hatron PY, Guery B, Faure K. Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults. MéDecine Et Maladies Infectieuses. 46: 87-92. PMID 26850899 DOI: 10.1016/J.Medmal.2015.12.013  0.331
2015 Guery B, Grandbastien B, Galpérine T, Faure K. Ebola et autres, ces virus venus d’ailleurs RéAnimation. 24: 379-385. PMID 32288742 DOI: 10.1007/S13546-014-1003-9  0.498
2015 Thépaut M, Grandjean T, Hober D, Lobert PE, Bortolotti P, Faure K, Dessein R, Kipnis E, Guery B. Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia. Veterinary Research. 46: 91. PMID 26338794 DOI: 10.1186/S13567-015-0239-3  0.793
2015 Hajji F, Beraud G, Genay A, Raoul G, Faure K, Guery B, Ferri J. Extensive Inflammatory Gingival Tumor in a Young Nonsmoking Woman: Back to Basics. The Journal of Craniofacial Surgery. 26: e388-90. PMID 26163848 DOI: 10.1097/Scs.0000000000001865  0.52
2014 Boukerb AM, Rousset A, Galanos N, Méar JB, Thépaut M, Grandjean T, Gillon E, Cecioni S, Abderrahmen C, Faure K, Redelberger D, Kipnis E, Dessein R, Havet S, Darblade B, et al. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection. Journal of Medicinal Chemistry. 57: 10275-89. PMID 25419855 DOI: 10.1021/Jm500038P  0.778
2014 Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. American Journal of Respiratory and Critical Care Medicine. 189: 799-811. PMID 24555512 DOI: 10.1164/Rccm.201307-1358Oc  0.775
2014 Mear JB, Gosset P, Kipnis E, Faure E, Dessein R, Jawhara S, Fradin C, Faure K, Poulain D, Sendid B, Guery B. Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response. Infection and Immunity. 82: 306-15. PMID 24166952 DOI: 10.1128/Iai.01085-13  0.79
2013 Méar JB, Kipnis E, Faure E, Dessein R, Schurtz G, Faure K, Guery B. Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association? Medecine Et Maladies Infectieuses. 43: 146-51. PMID 23622953 DOI: 10.1016/J.Medmal.2013.02.005  0.622
2013 Buyck JM, Verriere V, Benmahdi R, Higgins G, Guery B, Matran R, Harvey BJ, Faure K, Urbach V. P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 60-7. PMID 22809761 DOI: 10.1016/J.Jcf.2012.06.007  0.547
2012 Vuotto F, Faure K, Queyre V, Dessein R, Pasquet A, Lambert M, Haulon S, Beregi J, Guery B, Hatron P. Vascular nosocomial Nocardia farcinica infection after arterial stenting in an immunocompetent patient. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 22: e10-1. PMID 22379487 DOI: 10.1155/2011/216873  0.582
2012 Kipnis É, Dessein R, Faure K, Guery B. Les thérapeutiques anti-infectieuses non antibiotiques RéAnimation. 21: 303-316. DOI: 10.1007/S13546-012-0472-Y  0.539
2011 Ader F, Jawhara S, Nseir S, Kipnis E, Faure K, Vuotto F, Chemani C, Sendid B, Poulain D, Guery B. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Critical Care (London, England). 15: R150. PMID 21689424 DOI: 10.1186/Cc10276  0.774
2011 Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, Ader F, Lancel S, Courcol R, Guery BP, Faure K. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Critical Care Medicine. 39: 2113-20. PMID 21572326 DOI: 10.1097/Ccm.0B013E31821E899F  0.775
2009 Boutoille D, Marechal X, Pichenot M, Chemani C, Guery B, Faure K. FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin. Experimental Lung Research. 35: 263-71. PMID 19415544 DOI: 10.1080/01902140802632290  0.75
2009 Chemani C, Imberty A, de Bentzmann S, Pierre M, Wimmerová M, Guery BP, Faure K. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infection and Immunity. 77: 2065-75. PMID 19237519 DOI: 10.1128/Iai.01204-08  0.775
2008 Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Medicine. 34: 1646-53. PMID 18542921 DOI: 10.1007/S00134-008-1127-3  0.532
2008 Pierre M, Le Berre R, Tiesset H, Faure K, Guery B, Desseyn JL, Galabert C, Béghin L, Beermann C, Gottrand F, Husson MO. [Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model]. MéDecine Et Maladies Infectieuses. 38: 318-23. PMID 18455339 DOI: 10.1016/J.Medmal.2008.03.001  0.649
2008 Ader F, Le Berre R, Fackeure R, Raze D, Menozzi FD, Viget N, Faure K, Kipnis E, Guery B, Jarraud S, Etienne J, Chidiac C. In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model. Intensive Care Medicine. 34: 1511-9. PMID 18365173 DOI: 10.1007/S00134-008-1063-2  0.79
2008 Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Ader F, Courcol R, Guery BP, Faure K. Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 14: 337-43. PMID 18190582 DOI: 10.1111/J.1469-0691.2007.01925.X  0.362
2007 Ader F, Faure K, Guery B, Nseir S. [Pseudomonas aeruginosa and Candida albicans interaction in the respiratory tract: from pathophysiology to a therapeutic perspective]. Pathologie-Biologie. 56: 164-9. PMID 17905537 DOI: 10.1016/J.PATBIO.2007.06.002  0.313
2007 Pukenyte E, Nguyen S, Le Berre R, Faure K, Viget N, Melliez H, Mira JP, Guery B, Yazdanpanah Y. [Pneumonia with septicemia caused by Pasteurella multocida in an immunocompetent patient]. Medecine Et Maladies Infectieuses. 37: 354-6. PMID 17303362 DOI: 10.1016/J.Medmal.2006.05.018  0.396
2007 Ader F, Le Berre R, Lancel S, Faure K, Viget NB, Nowak E, Nevière R, Guery BP. Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia. Intensive Care Medicine. 33: 503-10. PMID 17219196 DOI: 10.1007/S00134-006-0497-7  0.785
2007 Buyck J, Faure K, Marechal X, Guery B, Matran R. 063 Is intracellular calcium concentration (Cai) in lung epithelial cells a signal for Pseudomonas aeruginosa type III secretion system (TTSS) activation ? Revue Des Maladies Respiratoires. 24: 1222. DOI: 10.1016/S0761-8425(07)74354-1  0.548
2006 Le Berre R, Faure K, Nguyen S, Pierre M, Ader F, Guery B. [Quorum sensing: a new clinical target for Pseudomonas aeruginosa?]. MéDecine Et Maladies Infectieuses. 36: 349-57. PMID 16631332 DOI: 10.1016/J.Medmal.2006.01.008  0.453
2006 Faure K, Leberre R, Guery B. [Pseudomonas aeruginosa and Surfactant-associated Proteins A and D]. Medecine Et Maladies Infectieuses. 36: 63-71. PMID 16406431 DOI: 10.1016/J.Medmal.2005.08.011  0.593
2006 Van Grunderbeeck N, Faure K, Husson M, Beermann C, Gottrand F, Guery B. 072 Augmentation de la Clairance Liquidienne Distale et potentialisation de la stimulation adrénergique par les acides gras n-3. Mise en évidence chez la souris Revue Des Maladies Respiratoires. 23: 550. DOI: 10.1016/S0761-8425(06)71900-3  0.458
2005 Boussekey N, Faure K, Guery B. Is combination the only issue? American Journal of Respiratory and Critical Care Medicine. 172: 1473-4; author reply. PMID 16301304 DOI: 10.1164/Ajrccm.172.11.1473  0.485
2005 Ader F, Le Berre R, Faure K, Gosset P, Epaulard O, Toussaint B, Polack B, Nowak E, Viget NB, Kipnis E, Guery BP. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system. Infection and Immunity. 73: 4263-71. PMID 15972518 DOI: 10.1128/Iai.73.7.4263-4271.2005  0.489
2005 Boyer S, Faure K, Ader F, Husson MO, Kipnis E, Prangere T, Leroy X, Guery BP. Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance. Respiratory Research. 6: 17. PMID 15707485 DOI: 10.1186/1465-9921-6-17  0.641
2004 Guery B, d'Escrivan T, Georges H, Legout L, Leroy O, Viget N, Faure K. [Viral pneumonia in immunocompetent patients]. Reanimation : Journal De La Societe De Reanimation De Langue Francaise. 13: 226-237. PMID 32288722 DOI: 10.1016/J.Reaurg.2004.02.009  0.605
2004 Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respiratory Research. 5: 1. PMID 15040820 DOI: 10.1186/1465-9921-5-1  0.487
2004 Le Berre R, Faure K, Fauvel H, Viget NB, Ader F, Prangère T, Thomas AM, Leroy X, Pittet JF, Marchetti P, Guery BP. Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance. Intensive Care Medicine. 30: 1204-11. PMID 14991100 DOI: 10.1007/S00134-004-2165-0  0.79
2004 d'Escrivan T, Faure K, Boussekey N, Soubrier S, Guery B. B-14 Facteurs de risque de bactéries multi-résistantes chez les patients admis en réanimation pour une bactériémie nosocomiale MéDecine Et Maladies Infectieuses. 34: S142. DOI: 10.1016/S0399-077X(04)90144-8  0.51
2004 Le Berre R, Ader F, Faure K, Robriquet L, Epaulard O, Gosset P, Toussaint B, Guery B. CL6-03 Le système de sécrétion de type III: Un facteur de virulence important dans la pneumonie à Pseudomonas aeruginosa (Pa) MéDecine Et Maladies Infectieuses. 34: S83. DOI: 10.1016/S0399-077X(04)90062-5  0.699
2003 Faure K, Fujimoto J, Shimabukuro DW, Ajayi T, Shime N, Moriyama K, Spack EG, Wiener-Kronish JP, Sawa T. Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model. Journal of Immune Based Therapies and Vaccines. 1: 2. PMID 12943554 DOI: 10.1186/1476-8518-1-2  0.426
2001 Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP. Therapeutic administration of anti-PcrV F(ab′)2 in sepsis associated with Pseudomonas aeruginosa Journal of Immunology. 167: 5880-5886. PMID 11698464 DOI: 10.4049/Jimmunol.167.10.5880  0.415
Show low-probability matches.